Distinction between Enterococcus faecium and Enterococcus lactis by a


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
21 12 2022
Historique:
pubmed: 2 12 2022
medline: 28 12 2022
entrez: 1 12 2022
Statut: ppublish

Résumé

It was recently proposed that Enterococcus faecium colonizing the human gut (previous clade B) actually corresponds to Enterococcus lactis. Our goals were to develop a PCR assay to rapidly differentiate these species and to discuss the main phenotypic and genotypic differences from a clinical perspective. The pan-genome of 512 genomes of E. faecium and E. lactis strains was analyzed to assess diversity in genes between the two species. Sequences were aligned to find the best candidate gene for designing species-specific primers, and their accuracy was tested with a collection of 382 enterococci. E. lactis isolates from clinical origins were further characterized by whole-genome sequencing (Illumina). Pan-genome analysis resulted in 12 gene variants, with gene

Identifiants

pubmed: 36453910
doi: 10.1128/spectrum.03268-22
pmc: PMC9769498
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0326822

Auteurs

Mireya Viviana Belloso Daza (MV)

Department for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.

Ana C Almeida-Santos (AC)

UCIBIO/REQUIMTE, Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Associate Laboratory, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.

Carla Novais (C)

UCIBIO/REQUIMTE, Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Associate Laboratory, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.

Antónia Read (A)

Clinical Pathology Service-Microbiology, Pedro Hispano Hospital, Matosinhos, Portugal.

Valquíria Alves (V)

Clinical Pathology Service-Microbiology, Pedro Hispano Hospital, Matosinhos, Portugal.

Pier Sandro Cocconcelli (PS)

Department for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.

Ana R Freitas (AR)

UCIBIO/REQUIMTE, Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Associate Laboratory, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.
TOXRUN - Unidade de Investigação em Toxicologia, Instituto Universitário de Ciências da Saúde, CESPU, CRL, Gandra, Portugal.

Luísa Peixe (L)

UCIBIO/REQUIMTE, Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Associate Laboratory, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH